InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.22
(
0.69%
)
US TECH 100
20,057.20
(
0.74%
)
Dow Jones
39,511.57
(
0.56%
)
Brent Oil
84.72
(
0.02%
)
Bitcoin
57,635.39
(
-0.66%
)
Post# of 689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

damnthetorpedoes

Send PM Follow Ignore
Followers 0
Posts 94
Boards Moderated 0
Alias Born 05/10/2012

damnthetorpedoes

Re: damnthetorpedoes post# 193

Friday, 05/11/2012 9:57:00 AM

Friday, May 11, 2012 9:57:00 AM

Post# of 689
Oh, well. I believe an RS is definitely off the table. What would be the point? At this level, even 1:6 won't get them listed.

Whatever you think about the science behind Poly's pipeline of products, it's obvious management knew about 56's issues long ago. I have to wonder what the thinking was when they started the 1B2 trial for LMWH. It seems to me they would have already encountered the blood pressure problems in the first trial.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up